These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 26245496

  • 21. EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
    Yeh DC, Chen DR, Chao TY, Chen SC, Wang HC, Rau KM, Feng YH, Chang YC, Lee KD, Ou-Yang F, Kuo WH, Chang KJ, Lin YC, Tseng LM, Hou MF.
    In Vivo; 2014; 28(5):1001-4. PubMed ID: 25189922
    [Abstract] [Full Text] [Related]

  • 22. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):e337-42. PubMed ID: 22763028
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
    Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, van der Linden Y, Ma B, Castro M, Arnalot PF, Ahmedzai S, Clemons M, Hoskin P, Yee A, Brundage M, Bottomley A, EORTC Quality of Life Group.
    Eur J Cancer; 2009 May 01; 45(7):1146-1152. PubMed ID: 19097882
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of health-related quality of life and its main influencing factors in a Polish population of patients with bone metastases.
    Püsküllüoğlu M, Zygulska AL, Tomaszewska IM, Ochenduszko S, Konopka K, Tomaszewski KA.
    Curr Probl Cancer; 2016 May 01; 40(5-6):183-197. PubMed ID: 27855962
    [Abstract] [Full Text] [Related]

  • 26. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A.
    Eur J Cancer Care (Engl); 2004 May 01; 13(2):135-44. PubMed ID: 15115469
    [Abstract] [Full Text] [Related]

  • 27. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E, Bottomley A.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct 01; 9(5):461-5. PubMed ID: 19817529
    [Abstract] [Full Text] [Related]

  • 28. Validation of EORTC IN-PATSAT32 for Chinese cancer patients.
    Zhang L, Dai Z, Cheng S, Xie S, Woo SM, Luo Z, Wu J, Gao T, Liu J, Zhang K, Zhang J, Jia X, Miller AR, Wang C.
    Support Care Cancer; 2015 Sep 01; 23(9):2721-30. PubMed ID: 25663542
    [Abstract] [Full Text] [Related]

  • 29. Validation of the Chinese version of EORTC QLQ-BN20 for patients with brain cancer.
    Zhang K, Tian J, He Z, Sun W, Pekbay B, Lin Y, Wu D, Zhang J, Chen P, Guo H, Wan Y, Wang M, Yang S, Zheng J, Zhang L.
    Eur J Cancer Care (Engl); 2018 Mar 01; 27(2):e12832. PubMed ID: 29461664
    [Abstract] [Full Text] [Related]

  • 30. Factors influencing health related quality of life in cancer patients with bone metastases.
    Wong E, Chow E, Zhang L, Bedard G, Lam K, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A.
    J Palliat Med; 2013 Aug 01; 16(8):915-21. PubMed ID: 23819731
    [Abstract] [Full Text] [Related]

  • 31. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY, Pakpour AH.
    Asian Pac J Cancer Prev; 2016 Aug 01; 17(3):1405-10. PubMed ID: 27039780
    [Abstract] [Full Text] [Related]

  • 32. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
    Cheng JX, Liu BL, Zhang X, Zhang YQ, Lin W, Wang R, Zhang YQ, Zhang HY, Xie L, Huo JL.
    BMC Med Res Methodol; 2011 Apr 22; 11():56. PubMed ID: 21513533
    [Abstract] [Full Text] [Related]

  • 33. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D, Bereza K, Sanna B, Kucharska E, Tomaszewska IM, Dudkiewicz Z, Skotnicki P, Bottomley A, Tomaszewski KA.
    Eur J Oncol Nurs; 2017 Aug 22; 29():148-154. PubMed ID: 28578847
    [Abstract] [Full Text] [Related]

  • 34. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M, Aaronson NK, Arraras JI, Basso U, Bumbasirevic U, Efficace F, Giesinger JM, Johnson CD, van Leeuwen M, Oberguggenberger AS, Sosnowski R, Young T, Holzner B, European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG).
    BMC Cancer; 2018 Nov 12; 18(1):1104. PubMed ID: 30419889
    [Abstract] [Full Text] [Related]

  • 35. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar R, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Support Care Cancer; 2016 Dec 12; 24(12):4871-4878. PubMed ID: 27465049
    [Abstract] [Full Text] [Related]

  • 36. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU.
    Oncology; 2008 Dec 12; 74 Suppl 1():7-12. PubMed ID: 18758191
    [Abstract] [Full Text] [Related]

  • 37. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M, Matthies L, Simoes E, Keilmann L, Hartkopf AD, Sokolov AN, Walter CB, Sickenberger N, Wallwiener S, Feisst M, Gass P, Fasching PA, Lux MP, Wallwiener D, Taran FA, Rom J, Schneeweiss A, Graf J, Brucker SY.
    J Med Internet Res; 2017 Sep 14; 19(9):e322. PubMed ID: 28912116
    [Abstract] [Full Text] [Related]

  • 38. Reliability, validity and responsiveness of the Mandarin (Simplified) Chinese version of the EORTC QLQ-OH45 among cancer patients.
    Liu J, Gao J, Wu CX, Bai DX, Li X, Guo XX, Yu JY, Xiao QQ, Bao XR, He LC, Zhong YZ, Chen S.
    Eur J Cancer Care (Engl); 2019 Mar 14; 28(2):e12987. PubMed ID: 30614580
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
    Kurosaka S, Satoh T, Chow E, Asano Y, Tabata K, Kimura M, Tsumura H, Matsumoto K, Ishiyama H, Inoue Y, Hayakawa K, Baba S.
    Ann Nucl Med; 2012 Jul 14; 26(6):485-91. PubMed ID: 22477263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.